Related Content
Download content relating to this event and topic.
No items found.
Biologics Nordics World 2026
7th Edition
Where Nordic Science Meets Global Scale
The leading Nordic summit for biologics, biosimilars, and CGT, connecting R&D, clinical, and manufacturing leaders to drive regional innovation.
Stockholm, Sweden
18
-
19
March 2026
00
Days
00
Hours
00
Mins
00
Secs
+
Attendees
300
Maximum Attendees
100
+
Companies
50
+
Speakers
12
+
Networking Hours
10
+
Case Studies
Interactive Sessions
About the Event
Where Nordic Science Meets Global Scale
Now in its 7th year, Biologics World Nordics is the region’s leading summit uniting biologics R&D, digital innovation, and GMP manufacturing.
Join pharma and biotech leaders from across the Nordics to explore the full biologics lifecycle: from discovery to commercial scale.
Featuring 2 focused tracks on R&D & Clinical Trials and Biologics Manufacturing, the summit spotlights the region’s strengths in innovation, process excellence, and sustainable bioproduction.
Connect with 100+ companies, hear from 50+ expert speakers, and engage in strategic discussions on R&D innovation, GMP scale-up, digitalisation, and partnerships shaping the future of biologics in the Nordics, from the heart of Nordic biotech innovation: Stockholm
Agenda at a Glance
View the Key Themes for
Biologics World Nordics 2026
R&D & Clinical Trials
Day 1 | 18 March 2026
- Steering the Nordic Biologics Engine
- Early-Phase Clinical Trial Design
- From Discovery to Operations
Day 2 | 19 March 2026
- AI in Drug Dicovery
- Future of Clinical Trials & Biosimilars
- Commers & Strategic Outlook
Biologics Manufacturing
Day 1 | 18 March 2026
- Strategies for Scaling & Efficiency
- Tech Transfer & Advanced Manufacturing
- Innovations in Downstream Processing
Day 2 | 19 March 2026
- The Digital Factory
- Future of Quality & Formulation
- Future-Proofing Production
Ready to attend?
Register today to secure your ticket.
Speakers
Esteemed Voices From the Industry
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Gnana Oli Rajaraman
AiCuris
Associate Director Bioanalytics Clinical Developments
Germany
Connect on LinkedInAdvisory Board Commitee
Chairman
Gnana Oli Rajaraman
Associate Director Bioanalytics Clinical Developments
AiCuris
Germany
Peter Ellmark
Alligator Bioscience
Chief Science Officer
Sweden
Peter Ellmark joined Alligator Bioscience in 2008 and serves as Chief Scientist. He holds a PhD and a professorship in Immunotechnology at Lund University and has more than 20 years’ experience of developing antibodies for immunotherapy of cancer. Dr. Ellmark´s research interest is focused on developing mono- and bispecific antibodies, in particular CD40 and 4-1BB targeting therapies, for tumor directed immunotherapy of cancer.
Advisory Board Commitee
Chairman
Peter Ellmark
Chief Science Officer
Alligator Bioscience
Sweden
Allan Jensen
Lundbeck
Vice President Biotherapeutic Discovery
Denmark
Dr. Allan Jensen is a biotherapeutics leader with expertise in antibody discovery and development for central nervous system (CNS) disorders. His work focuses on engineering next-generation biologic therapies, with particular emphasis on therapeutic monoclonal antibodies for neurodegenerative diseases. He has a strong background in molecular biology and structural biology, applying advanced protein engineering and molecular modeling techniques to overcome key challenges, such as delivering biologics across the blood-brain barrier. Dr. Jensen holds a Ph.D. in Molecular Biology from Aarhus University.
Advisory Board Commitee
Chairman
Allan Jensen
Vice President Biotherapeutic Discovery
Lundbeck
Denmark
Jonas Batelson
Curacell
Chief Executive Officer
Sweden
Jonas Båtelson is an entrepreneur and investor specializing in biopharma and digital health. He has extensive experience in innovation, strategic transformation, and large-scale commercial roll-outs across various segments of healthcare, life sciences, and technology. His work focuses on building and scaling new ventures, drawing on a strong background of over 15 years in management consulting. He applies this deep industry expertise to drive the successful launch and growth of companies in both Europe and the US.
Advisory Board Commitee
Chairman
Jonas Batelson
Chief Executive Officer
Curacell
Sweden
Lucas Arruda
Curacell
Chief Scientific Officer
Sweden
Dr. Arruda is a cancer immunotherapy specialist with expertise in TCR-T, TILs, CAR-T, and bispecific antibodies. His work focuses on developing next-generation cell and antibody-based therapies, with particular emphasis on TILs, T-cell and NK-cell engagers for solid and hematologic malignancies. He has a strong background in immune profiling and translational research, applying advanced technologies such as flow cytometry, next-generation sequencing, and single-cell analysis to accelerate the development of personalized immunotherapies.
Advisory Board Commitee
Chairman
Lucas Arruda
Chief Scientific Officer
Curacell
Sweden
Advisory Board Commitee
Chairman
Hakan Yildirim
Patent Lead
Alvotech
Sweden
Advisory Board Commitee
Chairman
Elhem Sbaa
Head of Regulatory Affairs
Cell2Cure
Denmark
Advisory Board Commitee
Chairman
Christine Hãgglund
VP CMC Dev
Scandinavian Biopharma
Sweden
Advisory Board Commitee
Chairman
Andrea Salmén
COO
Neogap Therapeutics
Sweden
Advisory Board Commitee
Chairman
Avik Ghosh
VP Manufacturing
Alvotech
Iceland
Advisory Board Commitee
Chairman
Kumar Ashesh
CEO
Paras Pharmaceuticals
Finland
Advisory Board Commitee
Chairman
Thomas Vestergaard Pedersen
Team Manager
Danish Medicine Agency
Denmark
Advisory Board Commitee
Chairman
Pankaj Kumar Jain
Senior Manager
Alvotech
Sweden
Advisory Board Commitee
Chairman
Vibhava Shukla
Director-Head of DS MSAT
Alvotech
Sweden
Want to Speak at This Event?
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Apply to SpeakRegistration
Choose a plan that fits your role, company, and industry.
PHARMA & BIOTECH
From £2199 + VAT
Priority Codes
Enter the below access codes at checkout to secure preferrential rates
EarlyBird
Save £600
(Valid until 31 December 2025, 23:59 GMT)
BioNord_Open
Save £400
(Valid until 12 February 2026, 23:59 GMT)
BioNord
Save £200
(Valid until 03 March 2026, 23:59 GMT)
*Standard ticket pricing is £2799+VAT without discount codes
SERVICE & SOLUTION PROVIDERS
From £2899 + VAT
Priority Codes
Enter the below access codes at checkout to secure preferrential rates
BioNord_EB
Save £1000
(Valid until 31 December 2025, 23:59 GMT)
BioNord_Open
Save £600
(Valid until 12 February 2026, 23:59 GMT)
BioNord
Save £300
(Valid until 03 March 2026, 23:59 GMT)
*Standard ticket pricing is £3899+VAT without discount codes
Registration
Register Your Interest
Be the first in line! Register your interest now to get exclusive access to Super Early-Bird tickets - the lowest prices available - before they go live.
Principal
No items found.
Platinum
No items found.
Gold
Silver
Bronze
Exhibition & Showcase
Associate
No items found.
Media & Publicity
No items found.
Want to Sponsor This Event?
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Pre Conference Workshops & Other Sessions
Visit the event page to view more content.
No items found.
Co-Located Events
Visit the event page to view more content.
Awards Cerermony
Visit the awards page to view more content.
Frequently Asked Questions
How can I stay updated on event details and announcements?
To stay informed about event updates, including date, venue, and agenda, please subscribe to our our official social media channels for real-time updates and announcements.
What can I expect to learn and explore during the event?
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
What safety measures will be in place to ensure the safety of attendees?
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Can I submit a presentation to be a speaker at this event?
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
What type of professionals benefit most from attending?
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
What advantages does this conference offer participants?
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Are there networking opportunities or special events planned?
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Are there sponsorship opportunities for this event?
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
How can I register for the event?
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Be a Part of This Event!
Don't miss out on unique networking, speaking and sponsorship opportunities.